Evaluation of Tolcapone as a Cognitive Enhancer in Schizophrenia

NCT06387771 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Tolcapone

Sponsor

Clinica Universidad de Navarra, Universidad de Navarra